Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study

The treatment of multiple myeloma (MM) with proteasome inhibitor (PI) bortezomib has significantly improved the survival of patients with MM. The 26S proteasome inhibitor targets the unfolded protein response (UPR) by inhibiting proteasome degradation of ubiquitinated paraprotein, subsequently leadi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Qin, Xiao-Qi, An, Gang, Li, Zeng-Jun, Liu, Lan-Ting, Xu, Yan, Yang, Lin-Hua, Ma, Yan-Ping, Deng, Shu-Hui, Sui, Wei-Wei, Qin, Yu, Feng, Xiao-Yan, Zang, Mei-Rong, Yang, Wen-Juan, Zhang, Yan-Ru, Yi, Shu-Hua, Wang, Ting-Yu, Lv, Rui, Zou, De-Hui, Zhao, Yao-Zhong, Qiu, Lu-Gui
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2019
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6418498/
https://ncbi.nlm.nih.gov/pubmed/30833275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018019851
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados